Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

METHODS Special Issue: Multiplexing Enables More Robust Surveillance for Avian Influenza

New assay developed for routine poultry monitoring

In the journal Methods, scientists from Wageningen Bioveterinary Research report the development of a multiplex assay for avian influenza. The assay is built on Luminex’s xMAP® Technology, and allows for serotyping all 16 hemagglutinin (HA) and 9 neuraminidase (NA) protein subtypes simultaneously.

Continue Reading >

xMAP® Connect



xMAP® Connect is structured to grow your network and to enable you to discover the endless applications of xMAP Technology. During the program, you will hear from multiplex experts about cutting-edge methods development and innovative projects from the research and clinical spaces, as well as connect with fellow researchers, Luminex partners, and Luminex specialists onsite.

Watch more videos >

Luminex on Twitter

RT @UF_ICBR: Join us for a @Luminex FLEXMAP 3D Lunch and Learn! Date: TODAY Time: 12:00 pm - 1:30 pm Location: CGRC 451
h J R
RT @tcdflow: Still time to register for the Imaging Flow Cytometry Open Day next Tues (Nov 19th) at @nuigalway . Contact Dagmar (dagmar.qua…
h J R
Whether it's #infectiousdisease, #immunology, cellsignaling, toxicity, allergy testing, #metabolism, or #serology,…
h J R

Latest News

November 4
Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA

October 25
Luminex Corporation To Release Third Quarter 2019 Results After Market Close On
November 4, 2019

October 1
Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay

September 26
Luminex Corporation to Present at the Cantor Global Healthcare Conference on
October 2, 2019

September 3
Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference


xMAP® Connect Amsterdam
November 5-6
Amsterdam, Netherlands

xMAP® Connect China
December 2019